Process Development

At Cambrex, we take a proactive and phase-appropriate approach to pharmaceutical process development and validation. Early drug development studies are traditionally designed to support fit-for-purpose manufacture of early clinical materials. As molecules progress, we help to create more cost-effective, robust and safe processes to manufacture the active pharmaceutical ingredient (API) for pilot and commercial production. Cambrex excels at turning early “med-chem” routes into commercially viable manufacturing routes during the drug development cycle.

We are structured to oversee custom small-molecule process development from early clinical phase to commercial production, and we offer a flexible manufacturing landscape, with small-, mid- and large-scale facilities designed to support customized solutions and seamless transfer of technologies.

Our development teams specialize in finding creative solutions to early-phase challenges while remaining focused on the rigors of validation. As a result, we can help you to avoid late-stage process changes, which could impact your speed to market. The result is more efficient preparation of your APIs and intermediates and greater confidence in your project’s success.


Discover a different CDMO

Looking for a partner that balances passion with painstaking attention to detail? Speak to one of our process development experts about how we can help you succeed.

Get in touch with an expert